Primary chemotherapy with doxorubicin followed by docetaxel-cisplatin in locally advanced breast cancer.

被引：0
|
作者：
Ezzat, A [1 ]
Rahal, M [1 ]
Twegieri, T [1 ]
Akhtar, S [1 ]
Al Sayed, A [1 ]
Ajarim, D [1 ]
Tulbah, A [1 ]
Al Malik, O [1 ]
Al Shabanah, M [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
703
引用
收藏
页码：52S / 52S
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant Doxorubicin followed sequentially by Cisplatin-Docetaxel in locally advanced breast cancer
    不详
    [J]. BREAST, 2005, 14 : S42 - S42
  • [2] Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
    Al-Tweigeri, Taher A.
    Ajarim, Dahish S.
    Alsayed, Adher A.
    Rahal, Mohamed M.
    Alshabanah, Mohamed O.
    Tulbah, Asma M.
    Al-Malik, Osama A.
    Fatani, Doha M.
    El-Husseiny, Gamal A.
    Elkum, Naser B.
    Ezzat, Adnan A.
    [J]. MEDICAL ONCOLOGY, 2010, 27 (03) : 571 - 577
  • [3] Prospective phase II study of neoadjuvant doxorubicin followed by cisplatin/docetaxel in locally advanced breast cancer
    Taher A. Al-Tweigeri
    Dahish S. Ajarim
    Adher A. Alsayed
    Mohamed M. Rahal
    Mohamed O. Alshabanah
    Asma M. Tulbah
    Osama A. Al-Malik
    Doha M. Fatani
    Gamal A. El-Husseiny
    Naser B. Elkum
    Adnan A. Ezzat
    [J]. Medical Oncology, 2010, 27 : 571 - 577
  • [4] Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
    Hirano, Akira
    Shimizu, Tadao
    Watanabe, Osamu
    Kinoshita, Jun
    Kimura, Kiyomi
    Kamimura, Mari
    Domoto, Kaoru
    Aiba, Motohiko
    Ogawa, Kenji
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4137 - 4142
  • [5] Preoperative induction chemotherapy with docetaxel-cisplatin followed by concurrent docetaxel-cisplatin and radiation therapy in patients with locally advanced esophageal cancer: A prospective, multicenter phase ll trial of the Swiss Group for Clinical Cancer Research
    Ruhstaller, T.
    Widmer, L.
    Majno, S. Balmer
    Mingrone, W.
    Hess, V.
    von Moos, R.
    Borner, M.
    Schnider, A.
    Koeberle, D.
    Popescu, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] A phase II trial of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.
    Lu, YS
    Kuo, SH
    Su, WP
    Yang, CH
    Hsu, C
    Yang, TL
    Huang, CS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 93S - 93S
  • [7] Docetaxel-cisplatin combined chemotherapy in Japanese patients with anthracycline-pretreated advanced breast cancer
    Kariya, S
    Ogawa, Y
    Nishioka, A
    Yoshida, S
    [J]. ONCOLOGY REPORTS, 2002, 9 (06) : 1345 - 1349
  • [8] Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Hashmi, Quratul Ain
    Abdullah, Famya
    Duraishi, Arif Moin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer
    Conti, F.
    Corsetti, S.
    Viola, G.
    Sperduti, I.
    Carpano, S.
    Pizzuti, L.
    Foggi, P.
    Perri, P.
    Anza, M.
    Toglia, G.
    Lopez, M.
    [J]. ONCOLOGY, 2009, 77 : 139 - 140
  • [10] Preoperative induction chemotherapy with docetaxel-cisplatin followed by concurrent docetaxel-cisplatin and radiation therapy (RT) in patients with locally advanced esophageal cancer: Final results of the multicenter phase II trial SAKK 75/02
    Schuller, J. C.
    Balmer-Majno, S.
    Mingrone, W.
    Hess, V.
    von Moos, R.
    Borner, M.
    Schnider, A.
    Koeberle, D.
    Popescu, R. A.
    Ruhstaller, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345